Zoekresultaten - Schwarer, Anthony

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study door Tan, Peter, Tiong, Ing Soo, Fleming, Shaun, Pomilio, Giovanna, Cummings, Nik, Droogleever, Mark, McManus, Julie, Schwarer, Anthony, Catalano, John, Patil, Sushrut, Avery, Sharon, Spencer, Andrew, Wei, Andrew

Volledige tekst Volledige tekst Volledige tekst

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML door Schwarer, Anthony P., Butler, Jason, Jackson, Kathryn, Beligaswatte, Ashanka, Martin, Louisa, Kennedy, Glen, Daniela, Zantomio, Lewis, Ian, Hiwase, Devendra, Wight, Joel, He, Simon, Grigg, Andrew, Morris, Kirk, Mollee, Peter, Marlton, Paula

Volledige tekst Volledige tekst Volledige tekst

Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells door Heatley, Susan L., Pietra, Gabriella, Lin, Jie, Widjaja, Jacqueline M. L., Harpur, Christopher M., Lester, Sue, Rossjohn, Jamie, Szer, Jeff, Schwarer, Anthony, Bradstock, Kenneth, Bardy, Peter G., Mingari, Maria Cristina, Moretta, Lorenzo, Sullivan, Lucy C., Brooks, Andrew G.

Volledige tekst Volledige tekst Volledige tekst

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia door Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée

Volledige tekst Volledige tekst Volledige tekst

Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia door Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée

Volledige tekst Volledige tekst Volledige tekst

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia door Tiong, Ing S., Dillon, Richard, Ivey, Adam, Teh, Tse‐Chieh, Nguyen, Phillip, Cummings, Nicholas, Taussig, David C., Latif, Annie‐Louise, Potter, Nicola E., Runglall, Manohursingh, Russell, Nigel H., Raj, Kavita, Schwarer, Anthony P., Fong, Chun Yew, Grigg, Andrew P., Wei, Andrew H.

Volledige tekst Volledige tekst Volledige tekst

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia door Fox, Lucy C., Cummins, Katherine D., Costello, Ben, Yeung, David, Cleary, Rebecca, Forsyth, Cecily, Tatarczuch, Maciek, Burbury, Kate, Motorna, Olga, Shortt, Jake, Fleming, Shaun, McQuillan, Andrew, Schwarer, Anthony, Harrup, Rosemary, Holmes, Amy, Ratnasingam, Sumita, Chan, Kah-Lok, Hsu, Wei-Hsun, Ashraf, Asma, Putt, Faye, Grigg, Andrew

Volledige tekst Volledige tekst Volledige tekst

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia door Minson, Adrian G., Cummins, Katherine, Fox, Lucy, Costello, Ben, Yeung, David, Cleary, Rebecca, Forsyth, Cecily, Tatarczuch, Maciek, Burbury, Kate, Motorna, Olga, Shortt, Jake, Fleming, Shaun, McQuillan, Andrew, Schwarer, Anthony, Harrup, Rosemary, Holmes, Amy, Ratnasingam, Sumita, Chan, Kah-Lok, Hsu, Wei-Hsun, Ashraf, Asma, Putt, Faye, Grigg, Andrew

Volledige tekst Volledige tekst Volledige tekst

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants door Cicconi, Laura, Testi, Anna Maria, Montesinos, Pau, Rego, Eduardo, Zhu, Hong Hu, Takahashi, Hiroyuki, Dworzak, Michael, Estey, Elihu, Schwarer, Anthony, Esteve, Jordi, Annibali, Ombretta, Castelli, Roberto, Mirabile, Milena, Angelini, Mario, Lazarevic, Vladimir, Kumar, Jeevan, Avvisati, Giuseppe, Gurnari, Carmelo, Locatelli, Franco, Voso, Maria Teresa, Sanz, Miguel Angel, Lo-Coco, Francesco, Abla, Oussama

Volledige tekst Volledige tekst Volledige tekst

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets door Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.

Volledige tekst Volledige tekst Volledige tekst

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease door Fajgenbaum, David C., Langan, Ruth-Anne, Japp, Alberto Sada, Partridge, Helen L., Pierson, Sheila K., Singh, Amrit, Arenas, Daniel J., Ruth, Jason R., Nabel, Christopher S., Stone, Katie, Okumura, Mariko, Schwarer, Anthony, Jose, Fábio Freire, Hamerschlak, Nelson, Wertheim, Gerald B., Jordan, Michael B., Cohen, Adam D., Krymskaya, Vera, Rubenstein, Arthur, Betts, Michael R., Kambayashi, Taku, van Rhee, Frits, Uldrick, Thomas S.

Volledige tekst Volledige tekst Volledige tekst

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts door Abboud, Camille, Berman, Ellin, Cohen, Adam, Cortes, Jorge, DeAngelo, Daniel, Deininger, Michael, Devine, Steven, Druker, Brian, Fathi, Amir, Jabbour, Elias, Jagasia, Madan, Kantarjian, Hagop, Khoury, Jean, Laneuville, Pierre, Larson, Richard, Lipton, Jeffrey, Moore, Joseph O., Mughal, Tariq, O’Brien, Susan, Pinilla-Ibarz, Javier, Quintas-Cardama, Alfonso, Radich, Jerald, Reddy, Vishnu, Schiffer, Charles, Shah, Neil, Shami, Paul, Silver, Richard T., Snyder, David, Stone, Richard, Talpaz, Moshe, Tefferi, Ayalew, Van Etten, Richard A., Wetzler, Meir, Abruzzese, Elisabetta, Apperley, Jane, Breccia, Massimo, Byrne, Jenny, Cervantes, Francisco, Chelysheva, Ekaterina, Clark, R. E., de Lavallade, Hugues, Dyagil, Iryna, Gambacorti-Passerini, Carlo, Goldman, John, Haznedaroglu, Ibrahim, Hjorth-Hansen, Henrik, Holyoake, Tessa, Huntly, Brian, le Coutre, Philipp, Lomaia, Elza, Mahon, Francois-Xavier, Marin-Costa, David, Martinelli, Giovanni, Mayer, Jiri, Milojkovic, Dragana, Olavarria, Eduardo, Porkka, Kimmo, Richter, Johan, Rousselot, Philippe, Saglio, Giuseppe, Saydam, Guray, Stentoft, Jesper, Turkina, Anna, Vigneri, Paolo, Zaritskey, Andrey, Aguayo, Alvaro, Ayala, Manuel, Bendit, Israel, Maria Bengio, Raquel, Best, Carlos, Bullorsky, Eduardo, Cervera, Eduardo, DeSouza, Carmino, Fanilla, Ernesto, Gomez-Almaguer, David, Hamerschlak, Nelson, Lopez, Jose, Magarinos, Alicia, Meillon, Luis, Milone, Jorge, Moiraghi, Beatriz, Pasquini, Ricardo, Pavlovsky, Carolina, Ruiz-Arguelles, Guillermo J., Spector, Nelson, Arthur, Christopher, Browett, Peter, Grigg, Andrew, Hu, Jianda, Huang, Xiao-jun, Hughes, Tim, Jiang, Qian, Jootar, Saengsuree, Kim, Dong-Wook, Malhotra, Hemant, Malhotra, Pankaj, Matsumura, Itaru, Melo, Junia, Ohnishi, Kazunori, Ohno, Ryuzo, Saikia, Tapan, Schwarer, Anthony P., Takahashi, Naoto, Tam, Constantine, Tauchi, Tetsuzo, Usuki, Kensuke, Wang, Jianxiang, Abdel-Rahman, Fawzi, Deeb Saeed Aljurf, Mahmoud, Bazarbachi, Ali, Ben Yehuda, Dina, Chaudhri, Naeem, Durosinmi, Muheez, Kamel, Hossam, Louw, Vernon, Francis Matti, Bassam, Nagler, Arnon, Raanani, Pia, Salem, Ziad

Volledige tekst Volledige tekst Volledige tekst